Hamim Zahir - Concepedia

Author

Hamim Zahir

Daiichi Sankyo (United States)ORCID

Also Known As

H Zahir, H. Zahir, Hamim Zahir, William Knebel

Publications

1.6K

Citations

H-Index

Concepts

All Affiliations

Daiichi Sankyo (United States)Daiichi-Sankyo (Japan)Daiichi Sankyo (Germany)Dana-Farber Cancer Institute The University of Sydney

About

Hamim Zahir is an author at Daiichi Sankyo (United States) specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	12	408
2	Health Sciences	2	2	44
3	Biochemistry	2	2	110
4	Social Sciences	1	1	11
5	Allergy	1	1	47

Hamim Zahir

Publications

1.5K

Citations

H-Index

Page 1

	Year	Citations
Edoxaban Effects on Bleeding Following Punch Biopsy and Reversal by a 4-Factor Prothrombin Complex Concentrate Hamim Zahir, Karen Brown, Alexander G. Vandell, Circulation	2014	250
Drug-Drug Interaction Studies of Cardiovascular Drugs Involving P-Glycoprotein, an Efflux Transporter, on the Pharmacokinetics of Edoxaban, an Oral Factor Xa Inhibitor Jeanne Mendell, Hamim Zahir, Nobuko Matsushima, American Journal of Cardiovascular Drugs	2013	221
Factors affecting variability in distribution of tacrolimus in liver transplant recipients Hamim Zahir, Geoffrey W. McCaughan, M. H. Gleeson, British Journal of Clinical Pharmacology	2004	112
Validation of methods to study the distribution and protein binding of tacrolimus in human blood Hamim Zahir, Romina A. Nand, Kenneth Brown, Journal of Pharmacological and Toxicological Methods BiochemistryMedicineBioanalysisPhysiologyProtein Binding	2001	98
Edoxaban drug–drug interactions with ketoconazole, erythromycin, and cyclosporine Dolly A. Parasrampuria, Jeanne Mendell, Minggao Shi, British Journal of Clinical Pharmacology	2016	94
Pharmacokinetics, Safety, and Tolerability of Teduglutide, a Glucagon‐Like Peptide‐2 (GLP‐2) Analog, Following Multiple Ascending Subcutaneous Administrations in Healthy Subjects Jean‐Francois Marier, Martin Béliveau, Samer Mouksassi, The Journal of Clinical Pharmacology	2008	75
Changes in Tacrolimus Distribution in Blood and Plasma Protein Binding Following Liver Transplantation Hamim Zahir, Geoffrey W. McCaughan, M. H. Gleeson, Therapeutic Drug Monitoring	2004	68
A phase 1 study of efatutazone, an oral peroxisome proliferator‐activated receptor gamma agonist, administered to patients with advanced malignancies Michael J. Pishvaian, John L. Marshall, Andrew J. Wagner, Cancer	2012	65
Population Pharmacokinetic Estimation of Tacrolimus Apparent Clearance in Adult Liver Transplant Recipients Hamim Zahir, Andrew J. McLachlan, A. Christie Nelson, Therapeutic Drug Monitoring Population Pharmacokinetic EstimationTherapeutic Drug MonitoringHepatologyPharmacokinetic ModelingMedicine	2005	60
A phase 2 multicenter study of tivantinib (ARQ 197) monotherapy in patients with relapsed or refractory germ cell tumors Darren R. Feldman, Lawrence H. Einhorn, David I. Quinn, Investigational New Drugs MedicineMetronomic TherapyPathologyArq 197Cancer Treatment	2013	53

Page 1